Abstract

Despite concerted efforts over decades, the etiology of multiple sclerosis (MS) remains unclear. Autoimmunity, environmental-challenges, molecular mimicry and viral hypotheses have proven equivocal because early-stage disease is typically presymptomatic. Indeed, most animal models of MS also lack defined etiologies. We have developed a novel adult-onset oligodendrogliopathy using a delineated metabolic stress etiology in myelinating cells, and our central question is, “how much of the pathobiology of MS can be recapitulated in this model?” The analyses described herein demonstrate that innate immune activation, glial scarring, cortical and hippocampal damage with accompanying electrophysiological, behavioral and memory deficits naturally emerge from disease progression. Molecular analyses reveal neurofilament changes in normal-appearing gray matter that parallel those in cortical samples from MS patients with progressive disease. Finally, axon initial segments of deep layer pyramidal neurons are perturbed in entorhinal/frontal cortex and hippocampus from OBiden mice, and computational modeling provides insight into vulnerabilities of action potential generation during demyelination and early remyelination. We integrate these findings into a working model of corticohippocampal circuit dysfunction to predict how myelin damage might eventually lead to cognitive decline.

Highlights

  • Features of multiple sclerosis (MS) include oligodendrocyte metabolic stress or cell loss, microglial and astroglial activation, demyelination and remyelination, ventricular enlargement and cortical atrophy, axonal spheroids, abnormal neurofilament biology and the large scale infiltration and activation of peripheral leukocyte populations[5,9,10,11,12,13]

  • To understand pathogenesis stemming from repeated episodic metabolic stress and induction of the unfolded protein response (UPR) in mature oligodendrocytes we developed the OBi mouse, which harbors three engineered genes (Plp1i.msd::McreG::Plp1Oex; Supplementary Fig. S1)

  • We demonstrate in optic nerve from 18 month mice gavaged weekly from 2 mo that approximately 25% of oligodendrocytes have undergone recombination

Read more

Summary

Introduction

Features of MS include oligodendrocyte metabolic stress or cell loss, microglial and astroglial activation, demyelination and remyelination, ventricular enlargement and cortical atrophy, axonal spheroids, abnormal neurofilament biology and the large scale infiltration and activation of peripheral leukocyte populations[5,9,10,11,12,13]. Developed or optimized to investigate the relationships between myelin-producing oligodendrocytes, the axons they ensheath and altered neuron function following oligodendrocyte damage or death[23,24,25,26,27] While these models facilitate exploration of MS pathobiology, a major limitation is that the associated pathogenic mechanisms are poorly characterized or unknown; they shed little light on etiology. A recent epitranscriptomics pilot study at the Universities of Connecticut and Stanford suggests that aberrant somatic RNA editing may give rise to expression of missense mutant PLP1 isoforms in active lesions from two MS patients[7] In this light, it is tempting to speculate that MS may arise clinically, not from immune invasion per se, but rather as a consequence of the interplay between chronic CNS metabolic disease and immune haplotype. This concept may be sufficiently broad to account for well-known correlations between disease activity and various environmental or genetic factors – climate, gender, pregnancy or switching from one anti-immune treatment to another

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call